Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study
Completed
Conditions studied: Soft Tissue Sarcoma
In brief
The purpose of this study is to assess the feasibility of conducting a large hospital based case control study of the role of dioxins and dioxinlike polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs).
Key facts
- Study ID
- NCT00611078
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 56
- Starts
- 2004-09-01
- Expected to finish
- 2011-01-01
- Last updated by the study team
- 2011-01-20
Who can join
Age: 18 and older, up to 79. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients with Soft tissue sarcoma at MSKCC are eligible for this study if they meet the following criteria:
- Between 18 and 79 years of age
- were diagnosed within the previous 6 months with primary soft tissue sarcoma of one of the following histologic subtypes: liposarcoma, leiomyoscaroma, MFH, or synovial sarcoma
- are enrolled in protocol 02-060 ("Novel Biochemical and Molecularr Determinants for Soft Tissue Sarcoma"; PI, Dr. Samuel Singer)
- controls will be eligibile for this study if they meet the following criteria
- are b/w 18-79 years of age
- have no prior history of cancer (other than non melanoma skin cancer)
You may not qualify if…
- Individuals will be excluded if they
- are unable to sign informed consent for medical or other reasons
- do not speak english
Where it is running
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.